Evaluation of the interaction of intravenous and oral voriconazole with oral cyclosporine in iranian HSCT patients

• Prif Awduron: Hamidreza Taghvaye Masoumi (Awdur), Molouk Hadjibabaie (Awdur), Mohammad Vaezi (Awdur), Ardeshir Ghavamzadeh (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Wolters Kluwer Medknow Publications, 2017-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Objective: Voriconazole as a triazole antifungal agent is widely used for prophylaxis or treatment of fungal infections in allogeneic hematopoietic stem cell transplantation (HSCT). It can increase blood concentrations of other medications including cyclosporine A (CsA) which are substrates for cyto...